ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Disease
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Respiratory Tract Diseases

Asthma trials near Pittsburgh, PA, USA:

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...

Active, not recruiting
Asthma (Diagnosis)
Drug: Placebo
Drug: WIN378

Phase 2

Windward Bio

Pittsburgh, Pennsylvania, United States and 72 other locations

This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma....

Enrolling
Mild to Moderate Asthma
Drug: CDX-622

Phase 1

Celldex Therapeutics
Celldex Therapeutics

Pittsburgh, Pennsylvania, United States and 3 other locations

immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...

Active, not recruiting
Asthma
Drug: Placebo
Drug: APG777

Phase 1

Apogee Therapeutics, Inc.

Pittsburgh, Pennsylvania, United States and 12 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Pittsburgh, Pennsylvania, United States and 134 other locations

Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Frevecitinib

Phase 2

Kinaset Therapeutics

Pittsburgh, Pennsylvania, United States and 14 other locations

trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Drug: Inhaled corticosteroids/long-acting beta-2 agonists

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Pittsburgh, Pennsylvania, United States and 116 other locations

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Active, not recruiting
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 77 other locations

levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...

Enrolling
Asthma
Drug: Brenipatide
Drug: Placebo

Phase 2

Lilly
Lilly

Pittsburgh, Pennsylvania, United States and 119 other locations

This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...

Enrolling
Eosinophilic Asthma
Drug: KT-621
Other: Placebo

Phase 2

Kymera Therapeutics

Pittsburgh, Pennsylvania, United States and 70 other locations

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma ...

Invitation-only
Asthma
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Pittsburgh, Pennsylvania, United States and 129 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems